Scientific Publications
Independent IBDX Clinical Studies
- Dotan, I., Fishman, S., Dgani, Y., Schwartz, M., Karban, A., Lerner, A., . . . Halpern, Z. (2006).
Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease.
Gastroenterology, 131(2), 366-378.
- Ferrante, M., Henckaerts, L., Joossens, M., Pierik, M., Joossens, S., Dotan, N., . . . Vermeire, S.
(2007). New serological markers in inflammatory bowel disease are associated with complicated disease
behaviour. Gut, 56(10), 1394-1403.
- Papp, M., Altorjay, I., Dotan, N., Palatka, K., Foldi, I., Tumpek, J., . . . Lakatos, P. L. (2008).
New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset,
Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort. The
American Journal of Gastroenterology, 103(3), 665-681.
- Simondi, D., Mengozzi, G., Betteto, S., Bonardi, R., Ghignone, R. P., Fagoonee, S., . . . Astegiano,
M. (2008). Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory
bowel disease. Inflammatory Bowel Diseases, 14(5), 645-651.
- Ferrante, M., Declerck, S., Coopmans, T., Hertogh, G. D., Assche, G. V., Penninckx, F., . . .
Vermeire, S. (2008). Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for
ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes.
Journal of Crohn's and Colitis, 2(2), 142-151.
- Seow, C. H., Stempak, J. M., Xu, W., Lan, H., Griffiths, A. M., Greenberg, G. R., . . . Silverberg, M.
S. (2009). Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype.
The American Journal of Gastroenterology, 104(6), 1426-1434.
- Verbeeten, D. S. (2009). GENETIC AND SEROLOGICAL MA RKERS ASSOCIATED WITH POUCHITIS AND A CROHN’S DI
SEASE-LIKE PHENOTYPE AFTER PELVIC POUCH SURGERY FOR ULCERATIVE COLITIS (Doctoral dissertation,
University of Toronto, 2009). Toronto: University of Tornonto.
-
Malickova, K., Lakatos, P. L., Bortlik, M., Komarek, V., Janatkova, I., & Lukas, M.
(2010). Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European
cohort. European Journal of Gastroenterology & Hepatology, 22(2), 144-150.
- Rieder, F., Schleder, S., Wolf, A., Dirmeier, A., Strauch, U., Obermeier, F., . . . Klebl, F. (2010).
Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with
complicated Crohnʼs disease behavior. Inflammatory Bowel Diseases, 16(2), 263-274.
- Rieder, F., Schleder, S., Wolf, A., Dirmeier, A., Strauch, U., Obermeier, F., . . . Klebl, F. (2010).
Serum anti-glycan antibodies predict complicated Crohnʼs disease behavior. Inflammatory Bowel Diseases,
16(8), 1367-1375.
-
Fakhraldeen, M., & H. S. (2010, June). Anticarbohydrate antibodies in patients with inflammatory bowel
disease. The Egyptian Journal of Hospital Medicine, 39, 260-267.
- Harrell, L. E., Weyer, G., Yarden, J., Dotan, N., & Hanauer, S. B. (2010). T1289 Anti-Glycan
Antibodies are Associated With Disabling Disease Course and Complicated Disease Behavior in Patients
With Crohn's Disease. Gastroenterology, 138(5)
- Koutroubakis, I. E., Drygiannakis, D., Tsirogianni, A., Oustamanolakis, P., Karmiris, K., Papamichael,
K., . . . Kouroumalis, E. A. (2010). Antiglycan Antibodies in Greek Patients with Inflammatory Bowel
Disease. Digestive Diseases and Sciences, 56(3), 845-852.
- Rieder, F., Hahn, P., Finsterhoelzl, L., Schleder, S., Wolf, A., Dirmeier, A., . . . Lang, T. (2012).
Clinical Utility of Anti-Glycan Antibodies in Pediatric Crohnʼs Disease in Comparison with An Adult
Cohort. Inflammatory Bowel Diseases, 18(7), 1221-1231.
- Prideaux, L. (2013). Inflammatory bowel disease serology in Asia and the West. World Journal of
Gastroenterology, 19(37), 6207.
- Sładek, M., Wasilewska, A., Świat, A., & Ćmiel, A. (2014). Serum anti-glycan antibodies in
paediatric-onset Crohn’s disease: Association with disease phenotype and diagnostic accuracy. Pg
Gastroenterology Review, 4, 232-241.
- Goren, I., Yahav, L., Tulchinsky, H., & Dotan, I. (2015). Serology of Patients with Ulcerative Colitis
After Pouch Surgery Is More Comparable with that of Patients with Crohnʼs Disease. Inflammatory Bowel
Diseases,
- Paul, S., Boschetti, G., Rinaudo-Gaujous, M., Moreau, A., Tedesco, E. D., Bonneau, J., . . . Roblin,
X. (2015). Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course. Journal of
Crohn's and Colitis, 9(6), 445-451.
Genetic, pathophysiology and pathogenesis
- Israeli, E., Grotto, I., Blank,
M., Anafi, L., Goldin, E., & Shoenfeld, Y.
(2006). Anti-Laminaribioside and
anti-Chitobioside Antibodies as Predictors of Crohn's Disease. DDW.
- Henckaerts, L., Pierik,
M., Joossens, M., Ferrante, M., Rutgeerts, P., & Vermeire, S. (2007). Mutations in
pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with
inflammatory bowel disease. Gut Online , 1536-1542.
-
Lakatos, P., Altorjay, I., Mándi, Y., Lakatos, L., Tumpek, J., Kovacs, A., et al.
(2008). Interaction between
seroreactivity to microbial antigens and genetics in Crohn’s disease: is there a role for defensins?
Tissue
Antigens , 71 (6), 552-559.
- Papp, M. (2009). Anti-microbial
antibodies in celiac disease: Trick or treat? World Journal of Gastroenterology, 15(31), 3891.
-
Joossens, M., Steen, K. V., Branche, J., Sendid, B., Rutgeerts, P., Vasseur, F., . . . Chamaillard, M.
(2010). Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohnʼs
disease. Inflammatory Bowel Diseases, 16(1), 58-67.
- Dotan, I., Meringer, H., Lerner,
A., Horowitz, N., Naftali, T., Yaron, A., et
al. (2010). Anti-glycan antibodies
are significantly increased in Crohn's disease patients and their first-degree relatives. DDW.
-
Rieder, F., Lopez, R., Franke, A., Wolf, A., Schleder, S., Dirmeier, A., . . . Klebl, F. (2011).
Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease – a Longitudinal
Analysis. PLoS ONE, 6(5).
- Vasseur,
F., Boualem, S., Broly, F., Gower-Rousseau, C., Sarazin, A., et al. (2013). The CARD8 p.C10X
mutation associates with low anti-glycans antibody response in patients with Crohn’s disease. BioMed
Central. 2013, 14:35. http://www.biomedcentral.com/1471-2350/14/35.
- Ahmed, I., Roy, B., Khan, S.,
Septer, S., & Umar, S. (2016). Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms,
4(2), 20.
-
Sokol H, Leducq V, Aschard H, et al
Fungal microbiota dysbiosis in IBD
Gut Published Online First: 03 February 2016.
Major Reviews
- Mitsuyama, Keiichi.
"Antibody Markers in the Diagnosis of Inflammatory Bowel
Disease." World Journal of Gastroenterology WJG 22.3 (2016): 1304.
- Kovács, Márta. "New
Serological Markers in Pediatric Patients with
Inflammatory Bowel Disease." World Journal of Gastroenterology 20.17 (2014): 4873.
- Prideaux, L., Cruz, P., Ng, S,
Kamm, M. (2012) Serological Antibodies in Inflammatory Bowel Disease: A
Systemic Review. Inflammatory Bowel Disease . 18:1340-1355
- Hanauer, S. (2011). Clinical and Biological Prognostic Markers in Crohn’s
Disease. US Gastroenterology &
Hepatology Review, , 7 (1), 17-22.
- Lakatos, P., Papp, M., & Rieder, F. (2011). Serologic Antiglycan Antibodies
in Infl ammatory. American
Journal of Gastroenterolgy , 106 (3), 406-412.
- Dotan, I. (2010). New Serologic Markers for Inflammatory Bowel Disease
Diagnosis. Digestive Diseases ,
28 (3), 418-423.
- Economou, M., & Pappas, G. (2008). New global map of Crohn's disease:
Genetic, environmental, and
socioeconomic correlations. Inflamatory Bowel Disease , 14 (5), 709-720.
- Dotan, I. (2007). Serologic markers in inflammatory bowel disease: tools for
better diagnosis and disease
stratification. Expert Review of Gastroenterolgy & Hepatology , 1 (2), 265-274.
- Papp, M., Norman, G., Altorjay, I., & Lakatos, P. (2007, April 14). Utility
of serological markers in
inflammatory bowel diseases: Gadget or magic? World Journal of Gastroenterology , 13 (14), pp. 2028-
2036.
- Abreu, M. (2006). Serologies in Crohn’s Disease: Can We Change the Gray Zone
to Black and White.
Gastroenterology , 131 (2), 664-667.